Monte Rosa Therapeutics (GLUE) Assets (2020 - 2026)
Monte Rosa Therapeutics' Assets was $691.16 million in Q2 2026, up 92.2% from $359.59 million a year earlier but down 6.1% from the prior quarter.
Monte Rosa Therapeutics (GLUE) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Assets at Monte Rosa Therapeutics came in at $448.66 million, up 2.3% from FY2024.
- Assets shows a five-year compound annual growth rate of 55.5% (FY2020 to FY2025).
- In earlier years, Assets was $438.73 million in FY2024 (+44.4%), $303.76 million in FY2023 (-11.3%), $342.39 million in FY2022 (-6.5%) and $366.33 million in FY2021 (+641.9%).
- Quarterly Assets has moved between $252.1 million (Q3 2023) and $736.43 million (Q1 2026) over five years.
- Compared with a year earlier, Assets has increased for nine straight quarters, with growth averaging 43.6% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q4 2021 (growth of 641.9%); the worst was Q3 2023 (a decline of 29.5%).
- Per Business Quant data, GLUE's Assets in the three quarters before Q2 2026 was $736.43 million (Q1 2026), $448.66 million (Q4 2025) and $459.84 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Monte Rosa Therapeutics | 1.08 Bn | 490.53 Mn | - | 691.16 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 691.16 Mn |
| Mar 31, 2026 | 736.43 Mn |
| Dec 31, 2025 | 448.66 Mn |
| Sep 30, 2025 | 459.84 Mn |
| Jun 30, 2025 | 359.59 Mn |
| Mar 31, 2025 | 393.20 Mn |
| Dec 31, 2024 | 438.73 Mn |
| Sep 30, 2024 | 315.08 Mn |
| Jun 30, 2024 | 344.11 Mn |
| Mar 31, 2024 | 266.75 Mn |
| Dec 31, 2023 | 303.76 Mn |
| Sep 30, 2023 | 252.10 Mn |
| Jun 30, 2023 | 278.62 Mn |
| Mar 31, 2023 | 309.03 Mn |
| Dec 31, 2022 | 342.39 Mn |
| Sep 30, 2022 | 357.60 Mn |
| Jun 30, 2022 | 365.06 Mn |
| Mar 31, 2022 | 346.01 Mn |
| Dec 31, 2021 | 366.33 Mn |
| Sep 30, 2021 | 384.05 Mn |
Monte Rosa Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=GLUE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "GLUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=GLUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();